anti psgl 1 Search Results


93
Bio X Cell monoclonal antibody
Monoclonal Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/InVivoMAb+anti-mouse+PSGL-1/ppr0818201-77-22-30
Average 93 stars, based on 1 article reviews
monoclonal antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Miltenyi Biotec mouse cd8a t cell isolation kit
Mouse Cd8a T Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/CD162+Antibody%2C+anti-human%2C+REAfinity/pmc12559718-397-18-26
Average 93 stars, based on 1 article reviews
mouse cd8a t cell isolation kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

91
Miltenyi Biotec anti cla
Anti Cla, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/CLA+Antibody%2C+anti-human/pmc09881277-77-141-143
Average 91 stars, based on 1 article reviews
anti cla - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

93
Miltenyi Biotec anti slan apc m dc8
Anti Slan Apc M Dc8, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/Slan+(M-DC8)+Antibody%2C+anti-human/pmc08951649-186-34-42
Average 93 stars, based on 1 article reviews
anti slan apc m dc8 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Miltenyi Biotec cla rea1101 recombinant human igg1
Cla Rea1101 Recombinant Human Igg1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/CLA+Antibody%2C+anti-human%2C+REAfinity/10__1038_slash_S41467___021___21774___4____41467_2021_21774_MOESM14_ESM-26-72-70
Average 90 stars, based on 1 article reviews
cla rea1101 recombinant human igg1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Boster Bio primary antibodies
Primary Antibodies, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/Anti-PSGL-1+SELPLG+Antibody/pm37679378-123-7-14
Average 90 stars, based on 1 article reviews
primary antibodies - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Selexys Pharmaceuticals Corporation monoclonal antibody anti-psgl-1 selk2
P-selectin and PSGL-1 regulate adhesion of MM cells to endothelial and stromal cells in vitro . Endothelial and stromal cells were treated with increasing concentrations of <t>SelG1</t> antibody (2.5, 5, and 10 μ g/mL) followed by adhesion of H929 or MM1.s cells labeled with calcein-AM. MM cell adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells (a). Likewise, H929 or MM1.s cells labeled with calcein-AM were incubated with increasing concentrations of SelK2 antibody (2.5, 5, and 10 μ g/mL) and plated on untreated endothelial and stromal cells, and the cell adhesion was measured as above (b). Stromal (c) and endothelial cells (d) were treated with SelG1 (10 μ g/mL) for 1 hr followed by plating MM1.s and H929 labeled with calcein-AM, and the adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells. Likewise, MM1.s and H929 were treated with SelK2 (10 μ g/mL) for 1 hr and plated on stromal (e) or endothelial cells (f), and the cell adhesion was measured as above. Values were considered significant for ∗ p < 0.05.
Monoclonal Antibody Anti Psgl 1 Selk2, supplied by Selexys Pharmaceuticals Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/monoclonal+antibody+anti+psgl+1+selk2/pmc04619821-42-3-12
Average 90 stars, based on 1 article reviews
monoclonal antibody anti-psgl-1 selk2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Immunotec inc anti-p-selectin glycoprotein ligand 1 (psgl-1)
P-selectin and PSGL-1 regulate adhesion of MM cells to endothelial and stromal cells in vitro . Endothelial and stromal cells were treated with increasing concentrations of <t>SelG1</t> antibody (2.5, 5, and 10 μ g/mL) followed by adhesion of H929 or MM1.s cells labeled with calcein-AM. MM cell adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells (a). Likewise, H929 or MM1.s cells labeled with calcein-AM were incubated with increasing concentrations of SelK2 antibody (2.5, 5, and 10 μ g/mL) and plated on untreated endothelial and stromal cells, and the cell adhesion was measured as above (b). Stromal (c) and endothelial cells (d) were treated with SelG1 (10 μ g/mL) for 1 hr followed by plating MM1.s and H929 labeled with calcein-AM, and the adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells. Likewise, MM1.s and H929 were treated with SelK2 (10 μ g/mL) for 1 hr and plated on stromal (e) or endothelial cells (f), and the cell adhesion was measured as above. Values were considered significant for ∗ p < 0.05.
Anti P Selectin Glycoprotein Ligand 1 (Psgl 1), supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/anti+psgl+1+mab+pl2/pmc02504360-74-0-11
Average 90 stars, based on 1 article reviews
anti-p-selectin glycoprotein ligand 1 (psgl-1) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioAlliance Pharma anti-psgl-1 antibodies
P-selectin and PSGL-1 regulate adhesion of MM cells to endothelial and stromal cells in vitro . Endothelial and stromal cells were treated with increasing concentrations of <t>SelG1</t> antibody (2.5, 5, and 10 μ g/mL) followed by adhesion of H929 or MM1.s cells labeled with calcein-AM. MM cell adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells (a). Likewise, H929 or MM1.s cells labeled with calcein-AM were incubated with increasing concentrations of SelK2 antibody (2.5, 5, and 10 μ g/mL) and plated on untreated endothelial and stromal cells, and the cell adhesion was measured as above (b). Stromal (c) and endothelial cells (d) were treated with SelG1 (10 μ g/mL) for 1 hr followed by plating MM1.s and H929 labeled with calcein-AM, and the adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells. Likewise, MM1.s and H929 were treated with SelK2 (10 μ g/mL) for 1 hr and plated on stromal (e) or endothelial cells (f), and the cell adhesion was measured as above. Values were considered significant for ∗ p < 0.05.
Anti Psgl 1 Antibodies, supplied by BioAlliance Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/anti+psgl+1+antibodies/us11692016-572-3-14
Average 90 stars, based on 1 article reviews
anti-psgl-1 antibodies - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
MBL Life science fitc tagged mouse-anti-psgl-1 mab pl1
Suspensions of isolated neutrophils were perfused through straight (St) and a constricted (310 msec) channel microfluidic devices, the effluents collected and labeled with an anti-PSGL-1 antibody <t>(PL1)</t> followed by a secondary antibody, and the expression level of PSGL-1 on the surface of neutrophils was analyzed by flow cytometry. Unsheared (Un) samples or samples incubated with 10nM PMA served as negative and positive controls. The data is shown as the mean fluorescent intensity ± standard error of the mean and is representative of five independent experiments with different donors. Statistical significance of the differences between the samples and the unsheared sample was measured using ANOVA with a Sidak post hoc test (*p<0.05).
Fitc Tagged Mouse Anti Psgl 1 Mab Pl1, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/fitc+tagged+mouse+anti+psgl+1+mab+pl1/pmc06673669-151-0-8
Average 90 stars, based on 1 article reviews
fitc tagged mouse-anti-psgl-1 mab pl1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GeneTex anti-human psgl-1 mab tb5
A-D. Wild-type HL-60s were cultured with 80 μM ONAP, SNAP or vehicle controls for 40 h. Flow cytometry measured cell surface carbohydrate structures using either fluorescent antibodies or lectins: PNA (binds Galβ1,3GalNAc, panel A), ECL (binds Galβ1,4GlcNAc, B), PHA-L (binds complex N-glycans, C), and CD15/Lewis-X (mAb HI98, D). Data in inset are mean fluorescence intensity ± SD for >3 independent experiments. * P<0.05 with respect to VC. SNAP increased PNA, ECL, and PHA-L bindings. ONAP has a smaller effect. E-F. Cell lysates run under standard reducing conditions, were probed with mAbs against mucinous proteins, anti-human PSGL-1 mAb <t>TB5</t> (panel E) and anti-human CD43 mAb L60 (F). SNAP reduced molecular mass of both glycoproteins indicating truncation on O-glycans. G. HL-60s were treated with 80 μM glycosides or vehicle control. Cell lysates were incubated with 10,000 dpm UDP-[14C]Gal (donor) in the presence or absence of 0.5 mM GalNAc-OBn (acceptor). [14C]Gal is preferentially added to SNAP present in cell lysates rather than GalNAc-OBn (left-half). Even in the absence of GalNAc-OBn, radioactive products are formed on SNAP and ONAP (right-half). H-J. HL-60s were cultured with 80 μM ONAP, SNAP or GalNAc, with 100 μM GalNAc-OBn being added after 8h in some cases. Products secreted into culture medium over 2 days were collected and quantitatively analyzed using LC-MS/MS. SNAP, and to a lesser extent ONAP, reduces glycan biosynthesis on GalNAc-OBn (panel H). Extended carbohydrate chains grew on SNAP (panel I) and ONAP (J). All assignments were verified by MS/MS. *P<0.05, **P<0.01 with respect to GalNAc. †: No detected.
Anti Human Psgl 1 Mab Tb5, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/anti+human+psgl+1+mab+tb5/pmc06474417-601-14-18
Average 90 stars, based on 1 article reviews
anti-human psgl-1 mab tb5 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bioconnect Systems Inc anti-psgl-1 mabs pl1
A-D. Wild-type HL-60s were cultured with 80 μM ONAP, SNAP or vehicle controls for 40 h. Flow cytometry measured cell surface carbohydrate structures using either fluorescent antibodies or lectins: PNA (binds Galβ1,3GalNAc, panel A), ECL (binds Galβ1,4GlcNAc, B), PHA-L (binds complex N-glycans, C), and CD15/Lewis-X (mAb HI98, D). Data in inset are mean fluorescence intensity ± SD for >3 independent experiments. * P<0.05 with respect to VC. SNAP increased PNA, ECL, and PHA-L bindings. ONAP has a smaller effect. E-F. Cell lysates run under standard reducing conditions, were probed with mAbs against mucinous proteins, anti-human PSGL-1 mAb <t>TB5</t> (panel E) and anti-human CD43 mAb L60 (F). SNAP reduced molecular mass of both glycoproteins indicating truncation on O-glycans. G. HL-60s were treated with 80 μM glycosides or vehicle control. Cell lysates were incubated with 10,000 dpm UDP-[14C]Gal (donor) in the presence or absence of 0.5 mM GalNAc-OBn (acceptor). [14C]Gal is preferentially added to SNAP present in cell lysates rather than GalNAc-OBn (left-half). Even in the absence of GalNAc-OBn, radioactive products are formed on SNAP and ONAP (right-half). H-J. HL-60s were cultured with 80 μM ONAP, SNAP or GalNAc, with 100 μM GalNAc-OBn being added after 8h in some cases. Products secreted into culture medium over 2 days were collected and quantitatively analyzed using LC-MS/MS. SNAP, and to a lesser extent ONAP, reduces glycan biosynthesis on GalNAc-OBn (panel H). Extended carbohydrate chains grew on SNAP (panel I) and ONAP (J). All assignments were verified by MS/MS. *P<0.05, **P<0.01 with respect to GalNAc. †: No detected.
Anti Psgl 1 Mabs Pl1, supplied by Bioconnect Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+psgl+1/anti+psgl+1+mabs+pl1/pm23601501-204-12-15
Average 90 stars, based on 1 article reviews
anti-psgl-1 mabs pl1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


P-selectin and PSGL-1 regulate adhesion of MM cells to endothelial and stromal cells in vitro . Endothelial and stromal cells were treated with increasing concentrations of SelG1 antibody (2.5, 5, and 10 μ g/mL) followed by adhesion of H929 or MM1.s cells labeled with calcein-AM. MM cell adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells (a). Likewise, H929 or MM1.s cells labeled with calcein-AM were incubated with increasing concentrations of SelK2 antibody (2.5, 5, and 10 μ g/mL) and plated on untreated endothelial and stromal cells, and the cell adhesion was measured as above (b). Stromal (c) and endothelial cells (d) were treated with SelG1 (10 μ g/mL) for 1 hr followed by plating MM1.s and H929 labeled with calcein-AM, and the adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells. Likewise, MM1.s and H929 were treated with SelK2 (10 μ g/mL) for 1 hr and plated on stromal (e) or endothelial cells (f), and the cell adhesion was measured as above. Values were considered significant for ∗ p < 0.05.

Journal: BioMed Research International

Article Title: Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib

doi: 10.1155/2015/417586

Figure Lengend Snippet: P-selectin and PSGL-1 regulate adhesion of MM cells to endothelial and stromal cells in vitro . Endothelial and stromal cells were treated with increasing concentrations of SelG1 antibody (2.5, 5, and 10 μ g/mL) followed by adhesion of H929 or MM1.s cells labeled with calcein-AM. MM cell adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells (a). Likewise, H929 or MM1.s cells labeled with calcein-AM were incubated with increasing concentrations of SelK2 antibody (2.5, 5, and 10 μ g/mL) and plated on untreated endothelial and stromal cells, and the cell adhesion was measured as above (b). Stromal (c) and endothelial cells (d) were treated with SelG1 (10 μ g/mL) for 1 hr followed by plating MM1.s and H929 labeled with calcein-AM, and the adhesion was assessed as a signal of adherent calcein-AM-positive MM cells measured by fluorescent reader and normalized to untreated cells. Likewise, MM1.s and H929 were treated with SelK2 (10 μ g/mL) for 1 hr and plated on stromal (e) or endothelial cells (f), and the cell adhesion was measured as above. Values were considered significant for ∗ p < 0.05.

Article Snippet: The humanized monoclonal antibodies anti-P-selectin (SelG1) and anti-PSGL-1 (SelK2) were obtained from Selexys Pharmaceuticals (Oklahoma City, OK).

Techniques: In Vitro, Labeling, Incubation

P-selectin and PSGL-1 affect proliferation of MM cells cocultured with endothelial and stromal cells in vitro . The effect of SelG1 antibody (10 μ g/mL) used on endothelial and stromal cells and SelK2 (10 μ g/mL) used on H929 cells on MM cell proliferation, with or without bortezomib (5 nM) treatment, analyzed by flow cytometry and normalized to untreated cells. Values were considered significant for ∗ p < 0.05.

Journal: BioMed Research International

Article Title: Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib

doi: 10.1155/2015/417586

Figure Lengend Snippet: P-selectin and PSGL-1 affect proliferation of MM cells cocultured with endothelial and stromal cells in vitro . The effect of SelG1 antibody (10 μ g/mL) used on endothelial and stromal cells and SelK2 (10 μ g/mL) used on H929 cells on MM cell proliferation, with or without bortezomib (5 nM) treatment, analyzed by flow cytometry and normalized to untreated cells. Values were considered significant for ∗ p < 0.05.

Article Snippet: The humanized monoclonal antibodies anti-P-selectin (SelG1) and anti-PSGL-1 (SelK2) were obtained from Selexys Pharmaceuticals (Oklahoma City, OK).

Techniques: In Vitro, Flow Cytometry

Suspensions of isolated neutrophils were perfused through straight (St) and a constricted (310 msec) channel microfluidic devices, the effluents collected and labeled with an anti-PSGL-1 antibody (PL1) followed by a secondary antibody, and the expression level of PSGL-1 on the surface of neutrophils was analyzed by flow cytometry. Unsheared (Un) samples or samples incubated with 10nM PMA served as negative and positive controls. The data is shown as the mean fluorescent intensity ± standard error of the mean and is representative of five independent experiments with different donors. Statistical significance of the differences between the samples and the unsheared sample was measured using ANOVA with a Sidak post hoc test (*p<0.05).

Journal: Cellular and Molecular Bioengineering

Article Title: Effects of Transient Exposure to High Shear on Neutrophil Rolling Behavior

doi: 10.1007/s12195-018-0533-z

Figure Lengend Snippet: Suspensions of isolated neutrophils were perfused through straight (St) and a constricted (310 msec) channel microfluidic devices, the effluents collected and labeled with an anti-PSGL-1 antibody (PL1) followed by a secondary antibody, and the expression level of PSGL-1 on the surface of neutrophils was analyzed by flow cytometry. Unsheared (Un) samples or samples incubated with 10nM PMA served as negative and positive controls. The data is shown as the mean fluorescent intensity ± standard error of the mean and is representative of five independent experiments with different donors. Statistical significance of the differences between the samples and the unsheared sample was measured using ANOVA with a Sidak post hoc test (*p<0.05).

Article Snippet: FITC tagged mouse-anti-PSGL-1 mAb PL1 was purchased from MBL (Woburn, MA), while unlabeled PL1 was purchased from Ancell (Bayport, MN).

Techniques: Isolation, Labeling, Expressing, Flow Cytometry, Incubation

A-D. Wild-type HL-60s were cultured with 80 μM ONAP, SNAP or vehicle controls for 40 h. Flow cytometry measured cell surface carbohydrate structures using either fluorescent antibodies or lectins: PNA (binds Galβ1,3GalNAc, panel A), ECL (binds Galβ1,4GlcNAc, B), PHA-L (binds complex N-glycans, C), and CD15/Lewis-X (mAb HI98, D). Data in inset are mean fluorescence intensity ± SD for >3 independent experiments. * P<0.05 with respect to VC. SNAP increased PNA, ECL, and PHA-L bindings. ONAP has a smaller effect. E-F. Cell lysates run under standard reducing conditions, were probed with mAbs against mucinous proteins, anti-human PSGL-1 mAb TB5 (panel E) and anti-human CD43 mAb L60 (F). SNAP reduced molecular mass of both glycoproteins indicating truncation on O-glycans. G. HL-60s were treated with 80 μM glycosides or vehicle control. Cell lysates were incubated with 10,000 dpm UDP-[14C]Gal (donor) in the presence or absence of 0.5 mM GalNAc-OBn (acceptor). [14C]Gal is preferentially added to SNAP present in cell lysates rather than GalNAc-OBn (left-half). Even in the absence of GalNAc-OBn, radioactive products are formed on SNAP and ONAP (right-half). H-J. HL-60s were cultured with 80 μM ONAP, SNAP or GalNAc, with 100 μM GalNAc-OBn being added after 8h in some cases. Products secreted into culture medium over 2 days were collected and quantitatively analyzed using LC-MS/MS. SNAP, and to a lesser extent ONAP, reduces glycan biosynthesis on GalNAc-OBn (panel H). Extended carbohydrate chains grew on SNAP (panel I) and ONAP (J). All assignments were verified by MS/MS. *P<0.05, **P<0.01 with respect to GalNAc. †: No detected.

Journal: Cell chemical biology

Article Title: Thioglycosides are efficient metabolic decoys of glycosylation that reduce selectin dependent leukocyte adhesion

doi: 10.1016/j.chembiol.2018.09.012

Figure Lengend Snippet: A-D. Wild-type HL-60s were cultured with 80 μM ONAP, SNAP or vehicle controls for 40 h. Flow cytometry measured cell surface carbohydrate structures using either fluorescent antibodies or lectins: PNA (binds Galβ1,3GalNAc, panel A), ECL (binds Galβ1,4GlcNAc, B), PHA-L (binds complex N-glycans, C), and CD15/Lewis-X (mAb HI98, D). Data in inset are mean fluorescence intensity ± SD for >3 independent experiments. * P<0.05 with respect to VC. SNAP increased PNA, ECL, and PHA-L bindings. ONAP has a smaller effect. E-F. Cell lysates run under standard reducing conditions, were probed with mAbs against mucinous proteins, anti-human PSGL-1 mAb TB5 (panel E) and anti-human CD43 mAb L60 (F). SNAP reduced molecular mass of both glycoproteins indicating truncation on O-glycans. G. HL-60s were treated with 80 μM glycosides or vehicle control. Cell lysates were incubated with 10,000 dpm UDP-[14C]Gal (donor) in the presence or absence of 0.5 mM GalNAc-OBn (acceptor). [14C]Gal is preferentially added to SNAP present in cell lysates rather than GalNAc-OBn (left-half). Even in the absence of GalNAc-OBn, radioactive products are formed on SNAP and ONAP (right-half). H-J. HL-60s were cultured with 80 μM ONAP, SNAP or GalNAc, with 100 μM GalNAc-OBn being added after 8h in some cases. Products secreted into culture medium over 2 days were collected and quantitatively analyzed using LC-MS/MS. SNAP, and to a lesser extent ONAP, reduces glycan biosynthesis on GalNAc-OBn (panel H). Extended carbohydrate chains grew on SNAP (panel I) and ONAP (J). All assignments were verified by MS/MS. *P<0.05, **P<0.01 with respect to GalNAc. †: No detected.

Article Snippet: Next, the proteins were transfer onto 0.2 μm nitrocellulose membrane, and probed with either anti-human PSGL-1 mAb TB5 (GeneTex, Irvine, CA) or anti-human CD43 mAb L60 (BD Biosciences).

Techniques: Cell Culture, Flow Cytometry, Fluorescence, Control, Incubation, Liquid Chromatography with Mass Spectroscopy, Glycoproteomics, Tandem Mass Spectroscopy